Neurodegenerative Drugs Comprehensive Study by Route of Administration (Oral, Injection, Transdermal, Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), Indication (Alzheimer Disease, Parkinson Disease, Multiple Sclerosis, Others), Drug Class (Glutamate Regulators, Decarboxylase Inhibitors, Dopamine Agonist, Cholinesterase Inhibitors, Others) Players and Region - Global Market Outlook to 2030

{reportSlug=global-neurodegenerative-drugs-market, reportId=85611, mktKeyword=Neurodegenerative Drugs, cagr=0.00, publishDate=Mar 2024, priceOption2=7000, reportTitle=Neurodegenerative Drugs Comprehensive Study by Route of Administration (Oral, Injection, Transdermal, Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), Indication (Alzheimer Disease, Parkinson Disease, Multiple Sclerosis, Others), Drug Class (Glutamate Regulators, Decarboxylase Inhibitors, Dopamine Agonist, Cholinesterase Inhibitors, Others) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=185, priceOption1=3800, forecastYr=2030, noOfPages=227, reportKey=85170, breadcrum=Global Neurodegenerative Drugs}